Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Rhythm Pharmaceuticals
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuroendocrine diseases. Its lead product, IMCIVREE (setmelanotide), targets rare genetic disorders of obesity, including pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, and leptin receptor (LEPR) deficiency obesity, as well as Bardet-Biedl and Alström syndromes. Rhythm Pharmaceuticals advances precision medicines that address the root causes of these conditions, aiming to transform the lives of affected patients.
Address
222 Berkeley Street, 12th Floor
Boston, 02116
United States
Year founded
2013
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add Rhythm Pharmaceuticals logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/rhythmtx.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
